Blog

Important drug development questions that model-based meta-analysis answers

Explore drug development questions that model-based meta-analysis answers, from competitive positioning to dose selection &…

Danielle Pillsbury2026 年 7 月 23 日

Conference

EANM 2026

–

Danielle Pillsbury2026 年 7 月 20 日

Webinar

Global Health Policy on the Move: Impact of MFN and EU HTA reform on Global and Regional Access

Certara2026 年 7 月 13 日

Blog

When to conduct hepatic impairment studies and when modeling may be enough

How to decide if a hepatic impairment study is required, choose the right study design,…

Certara2026 年 7 月 13 日

Conference

ASA Biopharmaceutical Section Regulatory-Industry Statistics Workshop

Certara2026 年 7 月 9 日

Blog

Dosimetry for radiopharmaceutical therapy: From measurement to dose justification

Why dosimetry for radiopharmaceutical therapy needs more than absorbed dose. How BED, radiation dosimetry &…

Hunter Stephens, PhD2026 年 7 月 7 日

Blog

Enhancing clinical trials with real-world evidence in pregnancy research

Learn how real-world evidence improves clinical trials in pregnancy by enhancing safety data, trial design,…

Certara2026 年 6 月 26 日

Guide

如何采用决策优先策略构建符合最佳实践的全球价值档案

Learn how a decision-first approach to value dossier preparation helps teams build pharma value dossiers…

Certara2026 年 6 月 25 日

Poster

开发人外周血单核细胞（PBMC）TXG-MAPr 模型，作为解释人类群体中毒理动力学变异性的机制框架

Leiden University and EFSA researchers present the PBMC TXG-MAPr — a network-based transcriptomic tool mapping…

Certara2026 年 6 月 23 日

Poster

利用来自大型健康志愿者队列的外周血单核细胞，对人类毒理动力学变异性进行特征分析

Research from Leiden University and EFSA characterizing interindividual toxicodynamic variability using peripheral blood mononuclear cells…

Certara2026 年 6 月 23 日

沪ICP备2022021526号

Powered by Translations.com GlobalLink Web Software

Certara 服务

Important drug development questions that model-based meta-analysis answers

EANM 2026

Global Health Policy on the Move: Impact of MFN and EU HTA reform on Global and Regional Access

When to conduct hepatic impairment studies and when modeling may be enough

ASA Biopharmaceutical Section Regulatory-Industry Statistics Workshop

Dosimetry for radiopharmaceutical therapy: From measurement to dose justification

Enhancing clinical trials with real-world evidence in pregnancy research

如何采用决策优先策略构建符合最佳实践的全球价值档案

开发人外周血单核细胞（PBMC）TXG-MAPr 模型，作为解释人类群体中毒理动力学变异性的机制框架

利用来自大型健康志愿者队列的外周血单核细胞，对人类毒理动力学变异性进行特征分析

订阅时事通讯

快捷链接

解决方案

联系我们